亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

AML14.3D10 Cell Line

技术优势
- Proprietary hematologic cell line - Ability to "switch" lineages and to produce GM-CSF in an autocrine fashion
技术应用
- Allergy Medications/Treatments- Asthma Medications/Treatments- Other Inflammatory Diseases
详细技术说明
None
*Abstract
The inventors have developed a hematologic cell line that contributes to a better understanding of normal and malignant hematology. Their AML14 cell lineΓÇÖs AML14.3D10 subclone has become the standard cell line model for the study of eosinophils, white blood cells in the human immune system responsible for combating multicellular parasites and certain infections in vertebrates. Along with mast cells, these cells control mechanisms associated with allergy and asthma. The cell lines were established from leukemic populations and most commonly exhibit features analogous to those found in normal immature cells of the myeloid lineage. Some of these cell lines can be induced to a more mature phenotypical state through chemical or biologic exposure. The AML14.3D10 cell line has been used to obtain important new information relevant to eosinophil biology.
*Principal Investigation

Name: Michael Baumann

Department:


Name: Cassandra Paul

Department:

国家/地区
美国

欲了解更多信息,请点击 这里
移动设备